Metabolic Syndrome Diagnosis and Education Trial
Metabolic Syndrome: Impact of Receiving the Diagnosis and Education Intervention on Cardiovascular Risk Factor Modification and Willingness to Change
1 other identifier
interventional
74
1 country
1
Brief Summary
This study is being done to gain knowledge on how effective different approaches of providing a diagnosis and varying educational tools that include DVDs and multimedia or printed instruction sheets on your readiness to increase the subject's level of exercise, lose more weight, eat a healthier diet; and to assess the subject's awareness of their risk of heart disease and their readiness to participate in a comprehensive lifestyle modification program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 20, 2009
CompletedFirst Posted
Study publicly available on registry
July 22, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedOctober 15, 2010
October 1, 2010
2.8 years
July 20, 2009
October 13, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Lifestyle Change: Readiness to Exercise, level of physical activity
6 weeks
Stages of Change for Exercise and for Fruits and vegetables
6 weeks
Study Arms (3)
Arm 1
EXPERIMENTALPatients randomized to this arm receive the diagnosis of "metabolic syndrome" and subsequent education using paper-based and DVD materials
Arm 2
EXPERIMENTALPatients in this arm receive the diagnosis of "metabolic syndrome" and subsequent education using paper-based material
Arm 3
NO INTERVENTIONPatients randomized to control receive the diagnosis of individual cardiovascular risk factors with paper-based educational material
Interventions
Patients will be told that they have the metabolic syndrome and will subsequently watch two 10-minute videos on the metabolic syndrome and on getting started with exercise. They also receive all the paper-based educational material as in arm 2
Patients will be told that they have the metabolic syndrome and will subsequently receive paper-based educational material on the metabolic syndrome,pre-diabetes, and hypertension. They also receive pamphlets on dietary management of high cholesterol and triglycerides, and the importance of exercise and weight loss.
Eligibility Criteria
You may qualify if:
- Any 3 of the following 5:
- History of hypertension or either systolic blood pressure \>125 or diastolic blood pressure \>85 mmHg or documented history and receiving treatment for it
- Abdominal circumference ≥40 inches in men or ≥35 inches in women
- Fasting triglycerides ≥ 150mg/dL or receiving treatment for it
- Fasting blood glucose ≥ 100mg/dL but \<126mg/dL
- HDL cholesterol \<40mg/dL in men or \<50mg/dL in women or receiving treatment for it
You may not qualify if:
- Documented diagnosis of metabolic syndrome in the clinical record, if previously seen at Mayo.
- History of coronary artery disease
- Diabetes mellitus, or using an oral hypoglycemic pill for glucose intolerance
- Congestive heart failure
- Familial hypercholesterolemia including familial hypertriglyceridemia,
- Fasting LDL-cholesterol \>160 mg/dL
- Fasting triglycerides \> 390 mg/dL
- Have systolic blood pressure \>160 and diastolic blood pressure \>100mg/dL
- History of hypertension with changes in their blood pressure medicines within the last 60 days before enrollment.
- History of dyslipidemia and changes on their lipid lowering agents such as statins, ezetimibe, fibrates or niacin within the last 60 days before enrollment.
- Secondary causes of obesity such as hypothyroidism, Cushing syndrome, or eating disorders
- Pregnant women or women planning to get pregnant during the duration of the study
- Advanced liver disease
- Renal insufficiency
- Having any other major chronic medical condition
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Related Publications (1)
Jumean MF, Korenfeld Y, Somers VK, Vickers KS, Thomas RJ, Lopez-Jimenez F. Impact of diagnosing metabolic syndrome on risk perception. Am J Health Behav. 2012 Jul;36(4):522-32. doi: 10.5993/AJHB.36.4.9.
PMID: 22488402DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randal J Thomas, MD, MS
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 20, 2009
First Posted
July 22, 2009
Study Start
October 1, 2007
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
October 15, 2010
Record last verified: 2010-10